The potential of PBPK modeling in answering key questions around these drugs.
Masoud Jamei, PhD
Advertisement
Senior Vice President, Research and Development, Certara
Articles by Masoud Jamei, PhD
Advertisement
Latest Updated Articles
Accelerating the Progress of Kinase Inhibitors in OncologyPublished: May 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI Everywhere: Architecting the Future of Clinical Trials
2
Balancing Human Oversight and Automation in AI-Driven Trials
3
AI in Action: Breaking Down Clinical Trial Bottlenecks
4
Unlocking the Potential of Agentic AI to Reduce Trial Delays
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
